Clinical Reference Laboratory Testing Services

1. INTRODUCTION The Defense Health Agency (DHA) is issuing this solicitation notice to inform industry of a requirement to provide Clinical Reference Laboratory Testing Services (CRLTS). This is a follow-on requirement to the services currently being performed under contract W81K04-21-D-0001, which is set to expire on June 30, 2026. 2. REQUIREMENT DESCRIPTION The Government requires a contractor to provide comprehensive, nonpersonal clinical reference laboratory testing services. The scope includes menu of approximately 6,960 specialized medical tests that the Government cannot perform in-house due to a lack of capability, capacity, or specialized infrastructure. These services will support approximately 205 Military Treatment Facilities (MTFs) globally. A critical technical requirement of this effort is the contractor's ability to establish and maintain a secure, bidirectional electronic interface between its commercial Laboratory Information System (LIS) and the Government's MHS Genesis electronic health record. The contractor must also meet stringent DoD cybersecurity requirements, including compliance with NIST SP 800-171 and the CMMC 2.0 framework, as will be detailed in the solicitation. 3. ACQUISITION STRATEGY The Government’s acquisition strategy is as follows: Competition: Full and Open Competition. Contract Vehicle: A single-award Indefinite Delivery/Indefinite Quantity (ID/IQ) contract. Period of Performance: A five-year base ordering period and one five-year optional ordering period, for a total potential ordering period of ten (10) years. Contract Type: Firm-Fixed-Price (FFP) task orders and/or Contract Ordering Official Card (COOC)/Government Purchase Card (GPC) orders. Source Selection Process: Performance Price Tradeoff (PPT), where non-price factors (e.g., Technical, Performance Risk, Small Business Subcontracting Participation), when combined, are significantly more important than price. 4. INCUMBENT INFORMATION The incumbent contractor for these services is LabCorp Inc., under contract W81K04-21-D-0001. 5. CHANGES Please note the following changes from the draft released on 6 May 2026: Inclusion of FAR Clause 52.222-90, Addressing DEI Discrimination by Federal Contractors, in accordance with Class Deviation 2026-O0040 Solicitation Issue Date (block 6) on the SF 1449 Offer Due/Date (block 8) on the SF 1449 6. QUESTIONS Questions are due no later than Monday, 18 May 2026 at 12:00 p.m. Central Time. Instructions for submitting questions are provided in Exhibit B. 7. ATTACHMENTS Please review the attached documents for full details: RFP HT001526RE001 Attachment 1 PWS Attachment 2 Addendum to FAR 52.212-1 Attachment 3 Addendum to FAR 52.212-2 Exhibit A – Price List Exhibit B - Clinical Reference Laboratory Testing Services QA Matrix Exhibit C – Past Performance Summary Sheet Exhibit D – Past Performance Questionnaire Exhibit E – Subcontractor Teaming Partner Letter and Table PWS Attachment 1 -Summary of DoD Sites PWS Attachment 2 – DD Form1423-1, System Security Plan PWS Attachment 3 – B2B Gateway Implementation Plan and Questionnaire PWS Attachment 4 – DHA CAC Request Process PWS Attachment 5 – Request for Common Access Card PWS Attachment 6 – Example of DHA Common Training PWS Attachment 7 - DD Form 2875 System Authorization Access Request PWS Attachment 8 – Performance Requirements Summary PWS Attachment 9 – Deliverables